US 11,952,354 B1
5-((2-isopropyl-5-methylphenoxy)methyl)-3-(naphthalen-2-yl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound
Hany Mohamed Abd El-Lateef Ahmed, Al-Ahsa (SA); Mai Mostafa Khalaf Ali, Al-Ahsa (SA); Antar Ahmed Abdelhamid Ahmed, Sohag (EG); and Amer A. Amer, Sohag (EG)
Assigned to KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed by KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed on Nov. 2, 2023, as Appl. No. 18/386,421.
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 271/06 (2006.01); A61P 31/04 (2006.01); A61P 31/10 (2006.01); A61P 35/00 (2006.01)
CPC C07D 271/06 (2013.01) [A61P 31/04 (2018.01); A61P 31/10 (2018.01); A61P 35/00 (2018.01)] 17 Claims
 
1. A 5-((2-isopropyl-5-methylphenoxy)methyl)-3-(naphthalen-2-yl)-1,2,4-oxadiazole compound having the formula I:

OG Complex Work Unit Chemistry